This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
There’s so many interesting new publications that don’t necessarily feature key molecules, but are helpful for drug hunters to know…
Article
1 year ago ●
6 mins read
IL-17 has been a hot target in immunology thanks to the clinical and commercial success of marketed anti-IL-17A and anti-IL-17RA…
molecule
6 months ago ●
2 mins read
Target-driven drug discovery evolves over time and is influenced by understanding of disease biology, technical innovation, and most of all,…
Article
1 year ago ●
13 mins read
Ziftomenib (KO-539) is an oral menin-MLL1 protein-protein interaction inhibitor being developed for acute myeloid leukemia (AML) by Kura Oncology. This…
molecule
6 months ago ●
3 mins read
In June 2022, the FDA approved vutrisiran (Amvuttra), a small interfering RNA (siRNA) for polyneuropathy of hereditary transthyretin-mediated (ATTR) amyloidosis…
Article
1 year ago ●
6 mins read
Mavacamten is a first-in-class oral, selective, allosteric cardiac myosin inhibitor, discovered by Myokardia and acquired by BMS in 2020 in…
molecule
6 months ago ●
2 mins read
Load More
